AFFERENT PHARMACEUTICALS
Afferent Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It develops medicines to treat chronic pain by targeting P2X3 receptors in nerve fibers. The company’s AF-219, a compound that completed two Phase 1 clinical studies. Afferent Pharmaceuticals, Inc. was founded in 2009 and is based in San Mateo, California.
AFFERENT PHARMACEUTICALS
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2009-01-01
Address:
San Mateo, California, United States
Country:
United States
Website Url:
http://www.merck.com
Total Employee:
11+
Status:
Active
Contact:
(650) 286-1276
Email Addresses:
[email protected]
Total Funding:
83.15 M USD
Technology used in webpage:
SPF Google Font API Microsoft Exchange Online Amazon Google Maps Microsoft Azure DNS GStatic Google Static Content Google Maps API MediaElement.js AWS Global Accelerator
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Eidos Therapeutics
Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Sparrow Pharmaceuticals
Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.
Current Advisors List
Founder
Investors List
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series C - Afferent Pharmaceuticals
Partner Fund Management
Partner Fund Management investment in Series C - Afferent Pharmaceuticals
New Leaf Venture Partners
New Leaf Venture Partners investment in Series C - Afferent Pharmaceuticals
Jennison Associates
Jennison Associates investment in Series C - Afferent Pharmaceuticals
Redmile Group
Redmile Group investment in Series C - Afferent Pharmaceuticals
Tekla Capital Management
Tekla Capital Management investment in Series C - Afferent Pharmaceuticals
Domain Associates
Domain Associates investment in Series B - Afferent Pharmaceuticals
Third Rock Ventures
Third Rock Ventures investment in Series B - Afferent Pharmaceuticals
Pappas Ventures
Pappas Ventures investment in Series B - Afferent Pharmaceuticals
Third Rock Ventures
Third Rock Ventures investment in Series A - Afferent Pharmaceuticals
Official Site Inspections
http://www.merck.com
- Host name: 192.0.66.119
- IP address: 192.0.66.119
- Location: San Francisco United States
- Latitude: 37.7506
- Longitude: -122.4121
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94110
